50 related articles for article (PubMed ID: 11179728)
1. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance.
Chen H; Hewison M; Hu B; Adams JS
Proc Natl Acad Sci U S A; 2003 May; 100(10):6109-14. PubMed ID: 12716975
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of New Type of Gemini Analogues with a Cyclopropane Moiety in Their Side Chain.
Gómez-Bouzó U; Peluso-Iltis C; Santalla H; Quevedo MA; Verlinden L; Verstuyf A; Fall Y; Gómez G; Rochel N
J Med Chem; 2024 Jun; 67(12):10386-10400. PubMed ID: 38858308
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.
Jusu S; Presley JF; Kremer R
J Biol Chem; 2017 Jan; 292(4):1490-1509. PubMed ID: 27852823
[TBL] [Abstract][Full Text] [Related]
4. Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1.
Keasey MP; Lemos RR; Hagg T; Oliveira JR
Sci Rep; 2016 May; 6():25802. PubMed ID: 27184385
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Short Term Vitamin D Supplementation on the Inflammatory and Oxidative Mediators of Arterial Stiffness.
Martins D; Meng YX; Tareen N; Artaza J; Lee JE; Farodolu C; Gibbons G; Norris K
Health (Irvine Calif); 2014 Jun; 6(12):1503-1511. PubMed ID: 25505940
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine.
Gupta GK; Agrawal T; Del Core MG; Hunter WJ; Agrawal DK
PLoS One; 2012; 7(8):e42789. PubMed ID: 22880111
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis.
Wu-Wong JR; Nakane M; Gagne GD; Brooks KA; Noonan WT
Int J Endocrinol; 2010; 2010():621687. PubMed ID: 20204178
[TBL] [Abstract][Full Text] [Related]
8. 1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells.
Artaza JN; Sirad F; Ferrini MG; Norris KC
J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):73-83. PubMed ID: 20064609
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells.
Artaza JN; Norris KC
J Endocrinol; 2009 Feb; 200(2):207-21. PubMed ID: 19036760
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.
Brancaccio D; Bommer J; Coyne D
Drugs; 2007; 67(14):1981-98. PubMed ID: 17883283
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol derivatives with two different side-chains at C-20. Part 4: further chain modifications that alter VDR-dependent monocytic differentiation potency in human leukemia cells.
Garay E; Jankowski P; Lizano P; Marczak S; Maehr H; Adorini L; Uskokovic MR; Studzinski GP
Bioorg Med Chem; 2007 Jul; 15(13):4444-55. PubMed ID: 17485214
[TBL] [Abstract][Full Text] [Related]
12. Single thyroid hormone receptor monomers are competent for co-activator-mediated transactivation.
Quack M; Carlberg C
Biochem J; 2001 Dec; 360(Pt 2):387-93. PubMed ID: 11716767
[TBL] [Abstract][Full Text] [Related]
13. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.
Bury Y; Herdick M; Uskokovic MR; Carlberg C
J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583
[TBL] [Abstract][Full Text] [Related]
14. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
15. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
Quack M; Carlberg C
Mol Pharmacol; 1999 Jun; 55(6):1077-87. PubMed ID: 10347251
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands.
Carlberg C
Recent Results Cancer Res; 2003; 164():29-42. PubMed ID: 12899512
[TBL] [Abstract][Full Text] [Related]
18. Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues.
Carlberg C; Quack M; Herdick M; Bury Y; Polly P; Toell A
Steroids; 2001; 66(3-5):213-21. PubMed ID: 11179728
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
